First published online 23 March 2005
doi: 10.1242/dev.01773
Development 132, 2235-2249 (2005)
Published by The Company of Biologists 2005
Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo
Raphaelle Grifone1,
Josiane Demignon1,*,
Christophe Houbron2,*,
Evelyne Souil3,
Claire Niro1,
Mary J. Seller4,
Ghislaine Hamard2 and
Pascal Maire1,
1 Département Génétique, Développement et Pathologie
Moléculaire, Institut Cochin INSERM 567, CNRS UMR 8104,
Université Paris V, 24 Rue du Faubourg Saint Jacques 75014 Paris,
France
2 Plateforme de recombinaison homologue, Institut Cochin INSERM 567,
CNRS UMR 8104, Université Paris V, 24 Rue du Faubourg Saint Jacques
75014 Paris, France
3 Plateforme d'histologie, Institut Cochin INSERM 567, CNRS UMR 8104,
Université Paris V, 24 Rue du Faubourg Saint Jacques 75014 Paris,
France
4 Division of Medical and Molecular Genetics, Guy's Hospital, London SE1 9RT,
UK
Author for correspondence (e-mail:
maire{at}cochin.inserm.fr)
Accepted 9 February 2005
 |
SUMMARY
|
|---|
In mammals, Six5, Six4 and Six1 genes are co-expressed
during mouse myogenesis. Six4 and Six5 single knockout (KO)
mice have no developmental defects, while Six1 KO mice die at birth
and show multiple organ developmental defects. We have generated
Six1Six4 double KO mice and show an aggravation of the phenotype
previously reported for the single Six1 KO. Six1Six4 double
KO mice are characterized by severe craniofacial and rib defects, and general
muscle hypoplasia. At the limb bud level, Six1 and Six4
homeogenes control early steps of myogenic cell delamination and migration
from the somite through the control of Pax3 gene expression. Impaired
in their migratory pathway, cells of the somitic ventrolateral dermomyotome
are rerouted, lose their identity and die by apoptosis. At the interlimb
level, epaxial Met expression is abolished, while it is preserved in
Pax3-deficient embryos. Within the myotome, absence of Six1
and Six4 impairs the expression of the myogenic regulatory factors
myogenin and Myod1, and Mrf4 expression becomes undetectable. Myf5 expression
is correctly initiated but becomes restricted to the caudal region of each
somite. Early syndetomal expression of scleraxis is reduced in the
Six1Six4 embryo, while the myotomal expression of Fgfr4 and Fgf8 but
not Fgf4 and Fgf6 is maintained. These results highlight the different roles
played by Six proteins during skeletal myogenesis.
Key words: Six/sine oculis homeoproteins, Pax3, Myogenesis, Hypaxial lip, Migration, Myotome, Syndetome
 |
Introduction
|
|---|
Six1 and Six4 genes belong to the sine
oculis/Six gene family that includes six members in vertebrates (from
Six1 to Six6), three members in Drosophila, four members in
Caenorhabditis elegans and at least two members in basal metazoans
(Kawakami et al., 2000
;
Pineda et al., 2000
;
Seo et al., 1999
;
Dozier et al., 2001
;
Bebenek et al., 2004
).
Originally, sine oculis was identified in Drosophila, where
it belongs to a network of genes that drives eye development synergistically
with eyeless (Pax orthologs), eyes absent and
dachshund (Cheyette et al.,
1994
; Pignoni et al.,
1997
; Serikaku and O'Tousa,
1994
). Absence of sine oculis leads to massive apoptosis
of precursor cells in the developing compound eye
(Cheyette et al., 1994
). In
Drosophila, two other sine oculis related genes have been
identified: optix, which is expressed in the eye imaginal disc
(Toy et al., 1998
); and dSIX4,
which is required for myoblast fusion
(Kirby et al., 2001
). In
vertebrates embryos, Six1 and Six4 expression have been detected in
overlapping territories: neural placodes, Rathke's pouch, DRG, dermomyotome,
myotome, limb bud mesenchyme and in myogenic migrating precursors
(Esteve and Bovolenta, 1999
;
Oliver et al., 1995
;
Ozaki et al., 2001
;
Bessarab et al., 2004
;
Fougerousse et al., 2002
;
Laclef et al., 2003a
;
Schlosser and Ahrens, 2004
).
This co-expression may reflect co-regulation of both genes, which are only
separated by 100 kb (Boucher et al.,
1996
). Six4/ mouse present with
no major developmental defects (Ozaki et
al., 2004
), while Six1/ mouse
neonates do not survive and have defects in many organs, including kidney
(Xu et al., 2003
), thymus,
parotid glands and ear (Laclef et al.,
2003b
; Zheng et al.,
2003
; Ozaki et al.,
2004
), and rib, craniofacial and muscle deficiencies
(Laclef et al., 2003a
;
Li et al., 2003
). Six1 is also
expressed at high levels in adult skeletal muscles where it participates, in
synergy with Eya1, in the establishment of the fast/glycolytic phenotype of
the myofiber (Grifone et al.,
2004
). With respect to muscle development, it has been shown that
Six1/ fetuses have a selective loss of
muscles including diaphragm, proximal and distal forelimb muscles, distal
ventral hindlimb muscles and abdominal muscles
(Laclef et al., 2003a
).
Back skeletal muscles are derived from somitic progenitors originating from
the epaxial dermomyotome. At the interlimb level, the lateral myotome and
dermomyotome produce the hypaxial muscles, including thoracic intercostal,
abdominal and limb muscles (Buckingham,
2001
). Extension of the lateral dermomyotome is under the control
of Pax3 (Williams and Ordahl,
1994
), and in Pax3/ mouse most hypaxial
migrating myogenic precursors are lacking
(Tremblay et al., 1998
).
Except for tongue muscles, which have a somitic origin, head muscle
progenitors originate from head paraxial mesoderm and migrate into the
pharyngeal arches to give rise to head and neck muscles
(Hacker et al., 1998
). Limb
muscles are formed by cells of the dermomyotome that delaminate from somites
and migrate into the limb bud where they further proliferate before activating
Mrf genes (Rees et al., 2003
).
Mrf activation, and more particularly Myf5, is under the control of different
signaling pathways, depending on the position of the myogenic precursors cells
in the embryo (Hadchouel et al.,
2003
; Tzahor et al.,
2003
). Delamination of myogenic precursors from the dermomyotome
is under the control of the Met tyrosine kinase receptor and scatter
factor/hepatocyte growth factor (SF/HGF) produced by the limb mesenchyme
(Bladt et al., 1995
;
Dietrich et al., 1999
).
Invasion of the limb by myogenic progenitors is also under the control of the
Lbx1 homeogene (Alvares et al.,
2003
). Both Lbx1 and Met expressions are under the control of
Pax3, as delamination and myoblast migration into the limb bud is prevented in
Pax3/ mice
(Bober et al., 1994
;
Epstein et al., 1996
;
Goulding et al., 1994
). Pax3
expression is not impaired in Six1/ embryos,
allowing myoblast migration and limb muscle formation
(Laclef et al., 2003a
). We
suggested that ontogenesis of most remaining axial and limb muscles present in
Six1/ embryos are under Six4 or Six5
control, as we detected Six5, Six4 and Pax3 expression in migrating myoblasts
of Six1/ embryos at the limb level
(Laclef et al., 2003a
) (data
not shown).
The sclerotome, another somitic compartment, gives rise to the axial
skeleton and ribs. Interactions between the incipient ribs and growing
myotomes at the intercostal level might occur through Fgf and Pdgf molecules
produced by the myotomes (Huang et al.,
2003
). In this context, inhibition of Fgf signaling causes
deletion of developing ribs (Huang et al., 2003b). The syndetome, which is
derived from the sclerotome, gives rise to the axial tendons. Scleraxis is one
of the earliest genetic marker characterized for this somitic lineage
(Schweitzer et al., 2001
).
Induction and individualization of the syndetome requires the
dermomyotome/myotome contact involving Fgf signaling
(Brent et al., 2005
).
To test the hypothesis that Six4 acts in common with Six1 during
myogenesis, we produced double Six1Six4 knockout (dKO) mice. We show
here that
Six1/Six4/
embryos develop a more severe muscle phenotype than did the
Six1/ embryo. No muscle is detected in the
limbs because of the downregulation of Pax3 in the ventral dermomyotomal lips
of the somites from which hypaxial progenitors arise. There is no
proliferation defects but most of these precursors migrate aberrantly, lose
their myogenic identity and die by apoptosis. Epaxial and non migrating
hypaxial musculature is affected by severely compromised expression of Mrf
genes within the myotome. Our results finally suggest that the rib phenotype
developed by
Six1/Six4/
fetuses could be the result of a loss of Mrf4 expression and a downregulation
of Fgf production in the myotome.
 |
Materials and methods
|
|---|
Construction of Six1-Six4 gene targeting vector
We isolated several Six4 genomic
FixII DNA clones from a
129Sv genomic library. We subcloned a 14 kb NotI-NotI
genomic fragment comprising the entire Six4 gene into pBluescript KS+
(Stratagene). A 3' 3.1 kb Nar-EcoRI fragment comprising the end
of the first intron and the beginning of the second Six4 exon was then ligated
in a plox2hygro plasmid leading to p3'Six4lox2hygro. A 5' DNA
region (NotI-Eco47III 4.2 kb fragment) was ligated in frame
into a pEGFP expression vector (Clontech). This 5' genomic fragment
possesses 3.2 kb DNA upstream of Six4 transcription initiation sites
as well as the first 144 amino acids. The 5'Six4-GFP fragment
was further cloned in p3'Six4lox2hygro, leading to the final
invalidation plasmid. Homologous recombination with this disruption vector was
expected to lead to the deletion of the last 370 amino acids of the first Six4
exon, including most of the Six domain and the entire homeodomain, which,
together, are responsible for the specific DNA-binding activity of Six4
protein.
ES cell screening and chimeric mouse production
Specific Six4 DNA fragment digested by NotI digestion (35 µg),
to eliminate plasmid DNA sequences, was electroporated (250V; 500 F) into
1.5x107 Six1-lacZ embryonic stem cells
(Laclef et al., 2003a
). ES
cells were selected with 150 µg/ml hygromycin 24 hours after
electroporation. The DNA of 310 Six1-Six4 resistant clones
was analyzed by Southern blot after PstI digestion. A 5'
fragment and a 3' fragments were used as external probes. Ten to 12
cells of three Six1-Six4 independent recombinant ES clones were microinjected
into C57BL6 blastocysts, which were further implanted into pseudopregnant
mice. Heterozygous progenies were obtained by backcrosses to C57BL6 and
129/SvJ females. All three clones were recombined on the Six1-lacZ
allele, as F1 animals from the three clones were either wild type or
heterozygous for both Six1 and Six4. F1 progeny was then crossed with EIIaCre
animals expressing the Cre recombinase ubiquitously under the control of E2A
promoter (Holzenberger et al.,
2000
). Deletion of the PGK-hygromycin cassette was ascertained by
Southern blot analysis. All homozygous embryos and fetuses have been genotyped
by Southern blot analysis.
X-gal staining, whole-mount skeletal staining, histology and
immunohistochemistry of the embryos were performed as described previously
(Laclef et al., 2003a
).
Vibratome section (120 µm) were performed after inclusion of the embryos in
4% agarose. Sections were then mounted in Kaiser's glycerol gelatin solution
(Merck). Gel mobility shift assays were performed as described
(Grifone et al., 2004
).
 |
Results
|
|---|
Generation of Six1Six4-deficient mice
Owing to the genetic proximity (about 100 kb) of Six1 and Six4 genes on
chromosome 12, invalidation of the Six4 gene was achieved in ES cells already
invalidated at the Six1 locus (Laclef et
al., 2003a
). Inactivation of the Six4 gene was achieved by
replacing the Six domain and homeodomain of the Six4 protein, both of which
are required for specific DNA binding, by the EGFP cDNA
(Fig. 1A). To identify the
recombination events at the Six4 locus that took place on the Six1 recombined
and wild-type allele, we analyzed the DNA of the progeny of chimeric animals
for both Six1 and Six4. In the three independent ES clones where recombination
events at the Six4 locus were identified, F1 DNA analysis showed that all
three recombination events occurred on the recombined Six1 allele, leading to
a Six1LacZSix4gfp/Six1+Six4+
genotype, hereafter referred to
Six1+/Six4+/. Southern
blot analysis with 5' and 3' external probes confirmed these
events (Fig. 1B).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 1. Targeted disruption of the Six4 gene. (A) Schematic representation of the
wild-type Six4-Six1 locus, with the restriction sites used in the
present study. The 4.2 kb 5' and 3.1 kb 3' homologous fragments
are indicated by double headed arrows. The Six4-loxP targeting fragment is
shown, and the two potential targeted Six4 mutant alleles after Cre excision
are depicted below. Schematic representations are not to scale. (B) Southern
blot analysis of genomic DNA digested by PstI and hybridized with a
5' external probe (above) and a 3' external probe (below), before
Cre recombination leading to a Six4hygrogfp allele, or after Cre
recombination leading to a Six4gfp allele. (C) Phenotype of wild
type (left) and
Six1/Six4/ (right)
newborn mice.
|
|
Six1+/Six4+/ animals
are viable and fertile, suggesting that one allele of Six1 and Six4 are
sufficient for correct development, either on 129SV or C57black6N backgrounds
(F8 generation). Indeed,
Six1/Six4/
animals die at birth and can be easily distinguished from their littermates.
They are smaller, have an enlarged abdomen and present severe craniofacial
malformations (Fig. 1C). In
contrast to Six1/,
Six1/Six4/
are earless, have open eyelids, a very reduced maxillary and mandible,
abnormally bent hindlimbs and forelimbs, and a general bent posture as if
dorsal musculature is inadequate.
Skeletal malformations in Six1/Six4/ newborn animals
Examination of the skeleton of E18.5
Six1/Six4/
fetuses revealed a more severe phenotype than was observed in
Six1/ fetuses
(Laclef et al., 2003b
). This
was most severe at the rib/sternum level, where the distal ribs were reduced
to small protrusions (Fig.
2B,C). None of the six
Six1/Six4/
fetuses analyzed in this study, on the two genetic mutant backgrounds, shows
rib attachment to the sternum (Fig.
2), whereas such attachments were observed occasionally in
Six1/ mutants
(Laclef et al., 2003a
). At the
cranial level, the mandible bone is drastically shortened and the fetuses have
small orbits with protruding eyes. Meckel cartilage is absent, jugal, nasal
and premaxilla bones are absent, the palatal process of the maxilla is
lacking, the squamosal bone is reduced, and the cartilages of the inner ear
and the ectotympanic bone are lacking (Fig.
2D,E, and data not shown). It thus appears that absence of Six4 in
a Six1/ background leads to a more severe
craniofacial and rib phenotype. In both forelimbs and hindlimbs, a clinodactly
(digit curvature) with a curved fifth digit was observed in all E18.5 fetuses
analyzed (n=6, Fig.
2F,G).

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 2. Skeletal defects in
Six1/Six4/
newborn mice as revealed by Alizarin Red (bones) and Alcian Blue (cartilage)
staining. (A,D,F)
Six1+/Six4+/ fetuses,
(B,C,E,G)
Six1/Six4/
fetuses. Lateral and ventral view (A-C) of the trunk skeleton, showing
truncation of the ribs, fusion and branching (black arrow in B). The sternum
is shortened (black arrow in C). (D,E) Lateral view at the head level showing
a shortened mandible bone (*), shortened squamosal bone devoid of
retrotympanic process (arrow) and lack of Meckel's cartilage (arrowhead) in
the dKO fetuses, and complete absence of ear structure (**). (F,G)
Dorsal view of hands of forelimbs at the left or hindlimbs at the right of
Six1+/Six4+/ (F) and
Six1/Six4/
fetuses (G) showing a clinodactily in the dKO. The fifth finger is curved
(arrows in G). (H) Human DNA samples from one individual with a 14q22 deletion
(1), and two control DNA samples (2,3). DNA was digested with BamHI
and hybridized with SIX1 cDNA (a, left panel) or SIX5 cDNA
(c, right panel), or digested with HindIII and hybridized with
SIX4 cDNA (b, middle panel). M.W., standard molecular weights. The
signal observed for SIX1 and SIX4 in the individual with the
14q22 deletion is half that one observed in the control DNA, while the signal
for SIX5 is comparable in all samples.
|
|
The phenotype of the transgenic mice was compared with a human condition
connected to the deletion of 14q22. This region comprises the SIX1,
SIX4 and SIX6 gene cluster of about 200 kb. We have previously
found that some of the human symptoms correspond to what can be observed in
Six1 homo- and heterozygous null mutant mice, such as hypotonia and
hypoplastic kidneys, while others (such as anophtalmia and pituitary
hypoplasia) were not observed in the Six1/
null (Bennett et al., 1991
;
Gallardo et al., 1999
;
Laclef et al., 2003b
;
Lemyre et al., 1998
;
Xu et al., 2003
). It has been
shown that in these individuals the SIX6 gene was deleted, suggesting
that anophtalmia and pituitary hypoplasia could be caused by SIX6
haploinsufficiency (Gallardo et al.,
1999
), which agrees with analysis of Six6 KO mice
(Li et al., 2002
). We
identified hemizygosity for both SIX1 and SIX4 genes in a
human 21-week-old fetus (Fig.
2H). This fetus had hypoplastic kidneys and clinodactily
(Bennett et al., 1991
),
suggesting that Six1 and Six4 haploinsufficiency could be responsible for
these developmental defects.
General muscle deficiencies in double Six1Six4 new born animals
We have shown previously that Six1/
fetuses present a severe but selective muscle hypoplasia, while
Six4/ fetuses are normal
(Laclef et al., 2003a
;
Ozaki et al., 2001
). As Six1
and Six4 are co-expressed during myogenesis, we suspected a compensatory role
for Six4 in the genesis of the remaining muscles of
Six1/ fetuses. X-gal staining of
Six1/Six4/
E18.5 fetuses revealed a more severe muscle phenotype than observed previously
in Six1/ fetuses
(Fig. 3A-L). All muscles of the
distal forelimb and hindlimb are missing, as revealed by the absence of any
fast or slow myosin positive fibers (Fig.
3I-L; data not shown), and all muscles of the proximal limbs are
missing as revealed by X-gal/Eosin staining
(Fig. 3A-D for the forelimb;
Fig. 3G,H for the hindlimb).
Hypaxial musculature at the trunk level is also severely diminished
(Fig. 3A,B) and most ventral
muscles are missing (see enlargement of
Fig. 3G,H). Back muscle masses
at the forelimb level and more rostrally are incorrectly shaped, while back
muscles at the interlimb level and at the hindlimb level show less
disorganization (Fig. 3E,F).
This suggests that Six1 and Six4 are dispensable for the formation of
remaining back muscle fibers because all of these muscles express
lacZ (Fig. 3C-F),
myosin heavy chains and desmin proteins (data not shown). Tendon formation did
not appear altered in these remaining muscles (data not shown). Most of the
head muscles, including the masseter, temporalis, pterygoid and extra-ocular
muscles are present at E18.5 (Fig.
3A,B; data not shown), showing that Six1 and Six4 are not required
for the formation of head muscles. However, while the mylohyoid is present,
the genioglossus muscle is absent and intrinsic tongue muscle is reduced (data
not shown) in dKO E18.5 fetuses.

View larger version (112K):
[in this window]
[in a new window]
|
Fig. 3. Absence of most skeletal muscles in
Six1/Six4/
E18.5 fetuses (A-L) and in
Six1/Six4/
E13.5 embryos (M-V). (A,C,E,G,I,K,M,O,Q,S,U)
Six1/+Six4/+ animals;
(B,D,F,H,J,L,N,P,R,T,V)
Six1/Six4/
animals. General view of E18.5 heterozygous (A) and double dKO (B) fetuses, as
revealed by X-gal staining. Skeletal muscles are absent from the limbs,
abdominal ventral muscles are missing and, at the shoulder and hip levels,
most muscles are lacking. X-gal Eosin staining on transversal sections (C-H)
or immunostaining performed with fast-type myosin heavy chain antibody My32
(I-L) confirmed the general axial muscle hypoplasia and that limbs have no
muscle. (C,D) Shoulder level, with the humerus (hu), thymus (thy) and vertebra
(v) indicated. Most muscles are lacking in the dKO fetuses, except epaxial
muscles, which appear incorrectly shaped, near the vertebral column. (E,F) Hip
level revealing deep back muscles in the control and dKO fetus. (G,H) Hip
level revealing that proximal muscles around the femur (fe) are lacking in the
dKO fetus, and that ventral-most muscles are also lacking (see enlargement of
the boxed ventral region. int, intestine. (I,J) Forelimb and (K,L) hindlimb
levels, revealing the absence of muscles in the dKO fetuses. r, radius; u,
ulna; t, tibia; f, fibula. General view of E13.5 heterozygous (M) and dKO (N)
fetuses, as revealed by X-gal staining. Abdominal ventral muscles are missing
and, at the shoulder level, most muscles are lacking. Transverse sections
(O-V) revealing desmin expression after immunostaining. (O,P) Eye level,
showing that most muscles are absent in the dKO embryo. Eo, extraocular
muscles; pt, pterigoid muscles; ca, capitalis muscles; nt, neural tube (Q,R)
Tongue level, revealing absence of tongue muscle (to) in the dKO embryo. Ma,
masseter. (S,T) Forelimb level, revealing absence of any desmin-positive cells
in the forelimb of dKO embryo. fl, forelimb; he, heart; db, deep back muscles;
st, spinotrapezius; cm, cutaneus maximus; ii, intercostals interni; bb, biceps
brachii, pe, pectoralis; tt, transversus thoracis. (U,V) Diaphragm level,
showing that ventral muscles and diaphragm are lacking in dKO embryos. li,
liver; dia, diaphragm; sm, scalenus medius; ie, intercostales externi; ra,
rectus abdominis; ta, transversus abdominis.
|
|
Primary myogenesis is severely disorganized in Six1/Six4/ embryos
A severe muscle hypoplasia was already apparent in embryonic forelimbs by
E13.5, as revealed by ß-gal staining
(Fig. 3M-N) and desmin
expression (Fig. 3S-T). There
is a total absence of desmin-positive myogenic cells in limbs. There is also a
disorganization of muscle masses at the back level, which is more obvious
rostrally to the forelimb (compare Fig. 3T
with 3V), and a total absence of myogenic cells in the abdominal
region (Fig. 3U-V). In the
head, most muscles are lacking at the eye level
(Fig. 3O-P) and the tongue
muscles are absent (Fig. 3Q-R),
while other muscles like the masseter are present
(Fig. 3Q-R). In the head, these
defects seem transient, as most head muscles are present by E18.5.
Severe myotomal disorganization in Six1/Six4/ embryos
Six1 and Six4 expression has been monitored by X-Gal staining and GFP
expression at different embryonic stages ranging from E9.5 to E12.5 on
wild-type and null backgrounds (Fig.
4). In E9.5-E10.5
Six1/Six4/
embryos, Six1 and Six4 genes are still highly expressed in
somites, suggesting that Six1 and Six4 proteins are not required for their own
transcription in these structures. Conversely, their gene expression is
severely reduced at the cranial level in the trigeminal placode and in the
otic vesicle, where X-Gal staining becomes barely detectable at E10.5
(Fig. 4E-H). These results
suggest either that in these cells Six1 and Six4 control positively their own
transcription, or that apoptosis occurs in these placodal precursors because
they require Six1 and Six4 to survive (see later). At E9.5, Six1 expression
was greatly reduced in the otic vesicle of
Six1/Six4/
embryo (Fig. 4, compare A,C
with B,D) probably reflecting a loss of
Six1/Six4/
cells through apoptosis (Ozaki et al.,
2004
; Zheng et al.,
2003
). At E9.5, the maxillary primordium and mandibular primordium
of the first and second branchial arches appeared fused (compare
Fig. 4C with 4D).

View larger version (89K):
[in this window]
[in a new window]
|
Fig. 4. X-Gal and GFP expression in heterozygous (A,C,E,G,I,K,M,O,Q,S,U,W,Y) and
homozygous mutant animals (B,D,F,H,J,L,N,P,R,T,V,X,Z) at E9.5 (A-D), E10.5
(E-P), E11.5 (Q-V) and E12.5 embryos (W-Z), revealing Six4-GFP
expression and Six1-lacZ expression. (A-D) Six1
expression is detected in the head mesenchyme (asterisk in A), otic vesicle
(white arrow in A), branchial arches (black arrow in A) and pharyngeal clefts
(white arrows in C) in heterozygous embryos. In dKO embryos, Six1 expression
at the head level is severely reduced (asterisk in B) and lost in the otic
vesicle (white arrow in B); although mesodermal Six1 expression is still
detected (D), most Six1 expression is lost in pharyngeal pouch endoderm and
surface ectoderm in dKO embryos. Fusion between the first and second branchial
arches is observed at this stage (white arrow in D). At the thoracic level,
the nephrogenic chord expression of Six1 is detected in the heterozygote
(black arrowhead in A) but not detected in the dKO embryo (black arrowhead in
B). At the somitic level, Six1 is expressed at comparable levels in the
heterozygous (A) and homozygous (B) animals. (E-P) Six1 is still highly
expressed in the ventral otic vesicle (white arrow in E,G) and trigeminal
ganglion (white arrowhead in E,G) in heterozygotes, but not in the dKO embryos
(white arrow and white arrowhead, respectively, in F and H). (G,H) Enlargement
of control (G) and KO (H) embryos at the head level. (I,J) Enlargement of
control (I) and KO (J) embryo at the interlimb level. At the somitic interlimb
level, Six1 expression is detected in the myotome (E,I). In the dKO,
Six1 expression is more diffuse, while still expressed in myotomes
(F,J). (K-P) Vibratome sections. At the hindlimb level (K,L), Six1 is
detected in the nephrogenic chord (arrow in K) but is not in the dKO, while
many ß-gal-positive cells invade this ventral region of the embryo (L).
Six1-positive cells enter the limb bud in the heterozygous embryos (K), but
not in the dKO embryo, where somitic ß-gal-positive cells are not
confined to the somite but are found more ventromedially (L). At the interlimb
level (M,N) Six1-positive cells are diffuse and do not extend ventrally in the
dKO embryo (N), while they invade ventral region in the heterozygous embryos
(M). Six1 expression in DRG is preserved, but a few ß-gal-positive cells
are also seen in the neural tube in the dKO (N,P; data not shown). At the
forelimb level (O,P), Six1-positive cells are present in the limb bud in the
heterozygous embryos (O), while in dKO embryos most cells accumulate less
ventrally, and are not found in the limb bud, but are also detected beneath
the ectoderm more medially (P). (Q-V) Six1 (Q, R) and Six4 (S-V) are mainly
detected in limbs, and somites, where they are co-expressed in the DRG,
myotomes, and ventral (black arrows) and dorsal dermomyotomal lips. In dKO,
somites still express these two genes (R,T). Myotomes are disorganized, their
ventral extensions are reduced (white double headed arrow), and GFP and
ß-gal are no longer detected in the ventral lips (black arrows). A
population of GFP and ß-gal-positive cells is found in the limbs of dKO
embryos but they are not myogenic cells
(Bonnin et al., 2005 ). (W-Z)
Six1 is expressed at higher levels in heterozygous (W,Y) than in homozygous
mutant embryos (X,Z). At the thoracic level, ventral extension of the
dermomyotome, normally marked by Six1 expression, is lost in dKO embryos
(white arrows). Posterior expression in the limbs is maintained.
|
|
At E10.5, Six1 and Six4 gene expression within each somite is largely
diffuse rostrocaudally and severely reduced ventrally
(Fig. 4I-P). Vibratome sections
through the dKO embryo show that ß-gal-positive cells are located
ventromedially at the hindlimb level and ventrolaterally beneath the ectoderm
at interlimb or forelimb levels (Fig.
4L,N,P), instead of extending ventrally or migrating into limb
buds as shown in control heterozygous embryos
(Fig. 4K,M,O). These mislocated
ß-gal-positive cells do not express Pax3, desmin or Myf5, and are
probably no longer myogenic precursor cells (see later). Six1 gene
expression in the DRG is not affected (Fig.
4M-P). At E11.5, Six1 and Six4 remain highly
expressed in the DRGs, as well as in myotome-like structures of each somite,
where their expression patterns appear more diffuse rostrocaudally and
mediolaterally, and severely diminished in their ventral extent
(Fig. 4U,V; data not shown).
Posterior domains of limb buds display strong expression of both genes
(Fig. 4Q-T) but these cells are
probably not myogenic, as they are also detected here in
Pax3/ (splotch) mice, which are devoid of
myogenic cells in limb buds (Oliver et
al., 1995
). Most notably, Six1 and Six4 gene expression is not
detected in the ventral and dorsal lips of the dermomyotome
(Fig. 4Q,R,U,V). At E12.5,
ß-gal-positive cells are dispersed in the
Six1/Six4/
somites when compared with the heterozygous
(Fig. 4W-Z). ß-Gal cells
also appear less abundant at this stage in the homozygote. It is also evident
that most of cells are blocked in their migration pathway, and fail to enter
the limb bud (Fig. 4L,N,P).
Mislocated cells in Six1/Six4/ embryos die by apoptosis
Whether Six1 and Six4 are important for the proliferation of myogenic
progenitors was first examined by the analysis of BrdU incorporation and
phospho-histone H3 expression. No significant difference of proliferation was
observed in the somites of E10-E11 dKO versus control embryos (data not
shown). We next analyzed confocal sections to evaluate the total number of
ß-gal-positive cells in one somite of E10.5 heterozygous and dKO embryos.
Analysis of seven serial sections at the hindlimb level showed that the number
of ß-gal-positive cells in the dKO (78±28) was significantly
greater (P<0.0005, Student's t-test) than in
heterozygotes (32±14), which reflects their failure to migrate to the
limb bud. At the abdominal level, we found 229 positive cells (±39) in
a heterozygous and 302 in a dKO (±89) (P<0.025), showing no
proliferation defects of
Six1/Six4/
cells at this level. At the forelimb level, we found 55 positive cells
(±19) in a heterozygous and 152 in a dKO (±39)
(P<0.0005). These results combined with the observation of
comparable levels of ß-gal and GFP accumulation in heterozygous and dKO
embryos (Fig. 4I,J,U,V)
indicated that at least until E10.5, the absence of Six1 and Six4 in vivo does
not prevent proliferation of the somitic myogenic precursors.
As
Six1/Six4/
fetuses were smaller than their littermate without proliferation defect in
somitic structures, at least between E10 and E11, we decided to examine the
extent of apoptosis in the dKO embryos. In contrast to control heterozygous
embryos, activated caspase 3-positive cells were detected at the ventral lip
level of dKO embryos at E10.5 (Fig.
5A-D), and later at E12.5 in cells which were rerouted ventrally
(Fig. 5E,F). These apoptotic
events were not specific to the somitic compartment as caspase 3-positive
cells were also found at E10.5 in branchial arches
(Fig. 5G,H).

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 5. Increased apoptosis in
Six1/Six4/
embryos. Sections (10 µm) of heterozygous (A,C) and dKO (B,D) embryos at
E10.5 at the hindlimb level, hybridized with antibodies revealing ß-gal
protein (A,B) and activated caspase 3 (C,D), showing activated caspase
3-positive cells only in dKO embryos (white arrow in D). Sections (10 µm)
of heterozygous (E) or dKO (F) embryos at E12.5 at the hindlimb level revealed
with antibodies against ß-gal protein (in red) and activated caspase 3
(in green), and showing apoptosis of ß-gal-positive cells in dKO embryos
that are rerouted ventrally (white arrow in F). Sections (10 µm) of
heterozygous (G) and dKO (H) embryos at E10.5 at the first branchial arch
level hybridized with antibodies revealing ß-gal protein (in red) and
activated caspase 3 (in green), and showing apoptosis of ß-gal-positive
cells in dKO embryos.
|
|
Impaired migration of myogenic precursors in Six1/Six4/ embryos is due to a decrease of Lbx1, Met and Pax3 expression
To further investigate the origin of limb muscle defects, the expression of
primordial myogenic markers was examined at E10.5 in dKO and heterozygous
embryos. In less mature caudal somites, Pax3 is expressed normally in the
dorsal neural tube and the dermomyotome of
Six1/Six4/
embryos (Fig. 6, part I, A-F).
In more rostral somites, at the hindlimb level, the ventralmost expression of
Pax3 is lower and no Pax3-positive cells have delaminated from the
dermomyotome to invade the limb bud (Fig.
6, part I, G-J). At the thoracic level, Pax3 expression in the
dorsal and ventral extensions of the dermomyotome is undetectable
(Fig. 6, part I, M-N) and Pax3
expression is only detected in caudal and rostral lips, where it is conversely
higher than in heterozygous embryos (Fig.
6, part I, K,L). At the forelimb level, Pax3 expression remains
detectable in the caudal lips but is not detected in dorsal and ventral lips.
Hence, Pax3 expression is also restricted to a central domain within the
somites and no Pax3-positive cells are detected in the forelimb
(Fig. 6, part I, O-R). More
rostrally in occipital somites, Pax3 expression is severely reduced
(Fig. 6, part I, A,B). In E9.5,
dKO embryos, Pax3 expression is also restricted to the caudal lips of the
dermomyotome of existing somites (data not shown).

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 6. Detection of Pax3 (part I), Met (part II), Lbx-1 (part III) and Pax7 (part
IV) by whole-mount in situ hybridization on E10.5 heterozygous and dKO
embryos. (Part I) Pax3 expression in heterozygous (A,C,E,G,I,K,M,O,Q) and dKO
embryos (B,D,F,H,J,L,N,P,R). Pax3 is still expressed in the dKO (B). At the
caudal level, in youngest somites Pax3 expression is initiated similarly in
both control and dKO embryo (C,D) and its dorsoventral expression domain is
comparable, as revealed by vibratome sections (E,F). At the hindlimb level,
ventral expression of Pax3 is perturbed (G-J) and no Pax3 myogenic precursor
delaminate to reach the limb bud. At the interlimb level (K-N), Pax3
expression is restricted to the posterior lip in the dKO embryo (arrow in L);
in ventral (arrow in N) and dorsal lips, expression is progressively lost
(L,N) when compared with wild-type expression (K,M). More rostrally at the
forelimb level Pax3 is only detected in the caudal lip of dKO embryos (P), and
completely lost in anterior, dorsal and ventral lips (P,R) when compared with
heterozygous embryos (O,Q). No myogenic precursor is detected in the limb bud
(R). Dorsal neural tube expression of Pax3 is conserved in dKO embryos along
the rostrocaudal level (F,J,N,R). In occipital somites, Pax3 expression is
very low in dKO embryos. (Part II) Comparison of Met expression in
heterozygous embryos (A,C,E,G), with its caudal expression in the top
right-hand corner of A, and in dKO embryos (B,D,F,H), with its caudal
expression in the bottom left-hand corner in B. Although Met expression is
correct in the two first caudal somites of dKO embryos, most expression is
lost in more rostral somites, and ectodermal expression is detected at the
interlimb level in dKO embryos (arrow in B). Transverse sections through
embryos at hindlimb level (C,D), interlimb levels (E,F) and forelimb bud
levels (G,H). At the hindlimb level, Met can be detected in dorsal and ventral
dermomyotomal lips (D) and few cells are detected in the hindlimb bud
in caudal-most areas of this limb bud (arrow in D); however, Met expression is
lost more rostrally from these hindlimb somites. The central somitic
expression of Met is faint and restricted (H) at the forelimb level
(arrowhead). Epaxial Met expression (white arrow in A) is lost in dKO embryos
(white arrow in B). (Part III) Lbx1 expression in wild-type (A,C,E) or KO
(B,D,F) embryos. Lbx1 expressed at the hypoglossal chord (arrow in C and D)
and forelimb bud levels (asterisks in C and D) is abrogated in dKO embryos but
still faintly detected in a few somites at the hindlimb level (arrowhead in
F). (G) Bandshift assays performed with recombinant Eya1, Six1 or Six1+Eya1
proteins on a potential MEF3 site present in the promoter of mouse
Lbx1 gene showing formation of a MEF3Lbx-Six1 or a
MEF3Lbx-Six1-Eya1 DNA protein complex. (Part IV) Pax7 expression in
heterozygous (A,C,E,G,I) and KO (B,D,F,H,J) embryos. Pax7 is expressed in
dermomyotome and its expression pattern is mainly unchanged in KO somites
(C,D) at the hindlimb level, as revealed by vibratome sections (E,F), and at
the interlimb level (G,H). At the forelimb bud level, we noticed that
dorsoventral extension of the expression domain of Pax7 was reduced (I,J).
|
|
Met expression is not affected in the most caudal somites of dKO embryos
(Fig. 6, part II, A,B), but it
declines more rostrally (Fig.
6, part II: A,B,E,F). In somites facing the hindlimb, Met is
poorly detectable in the ventral dermomyotome and only a few Met-positive
cells are detected in the limb (Fig.
6, part II, C,D). At the interlimb level, Met is mainly detected
in ectodermal structures. The absence of Met in the ventral dermomyotome
coincides with the downregulation of Pax3, while its downregulation in the
epaxial domain is specific to the Six1Six4 dKO. At the forelimb
level, a weak Met expression is detected in the centre of the somite
(Fig. 6, part II, H) where Pax3
was also restricted (Fig. 6,
part I, R). This Met expression domain is not observed in heterozygous or
wild-type embryos (Fig. 6, part
II, G), probably because of a low Pax3 expression
(Fig. 6, part I, Q). However,
this level of Met appears insufficient to allow myoblast migration as no
myogenic precursors are detected in the forelimb of dKO embryos.
Lbx1 expression is not detected at forelimb and hypoglossal chord levels in
dKO embryos when compared with the control
(Fig. 6, part III, A-D). Lbx1
is weekly detectable in three out of the six Lbx1-expressing somites facing
the hindlimb bud (Fig. 6, part
III, E,F), corresponding to sacral somites where Met and Pax3 are expressed
ventrally. Lbx1 was not detected in occipital somites and at the forelimb
level in E9.5 dKO embryos (data not shown).
Bandshift assays using a potential MEF3 site (TCAGGTTTC) found in the human
and mouse Lbx1 promoter (TCAGGTTggC) as a probe together with nuclear extracts
or in vitro synthesized Six1 protein, demonstrated a specific interaction of
Six proteins with the Lbx1 promoter (Fig.
6, part III, G; data not shown). Hence, Lbx-1 may be under the
control of Six proteins, at least in a population of myogenic migrating
precursors. Nonetheless, the presence of a few Lbx-1 positive cells in the
hindlimb suggests that some specific myogenic precursors can activate Lbx1 and
Met in the absence of Six1 and Six4 homeogenes.
Finally, at hindlimb and interlimb levels, no major difference in Pax7
expression, another dermomyotomal marker, is detected between control and dKO
embryos (Fig. 6, part IV, C,D).
However, at the forelimb level, Pax7 is slightly reduced in the ventral and
dorsal dermomyotome in the dKO embryo (Fig.
6, part IV, I,J).
Pax3 expression in the dermomyotome is under the control of Six1 and Six4
We next performed double immunofluorescence on transverse sections of E10.5
embryos to detect both Pax3 and lacZ expression, the latest
reflecting the presence of cells that turned on Six1 gene expression
(Fig. 7). Caudally to the
hindlimb in both heterozygous and homozygous embryos, Pax3 and Six1 are
co-expressed in the entire epithelial dermomyotome
(Fig. 7A-D). At the hindlimb
level in heterozygous embryos, Pax3 and Six1 are still co-expressed in the
entire dermomyotome, in migrating myoblasts, and in laminin- and
desmin-positive myotomal cells (Fig.
7E-F,I-J). In caudalmost somites facing the hindlimb of dKO
embryos, Pax3 and Six1 genes are co-expressed ventrally in a region where
there was no lateral migration to the limb
(Fig. 7G-H) and in some
laminin- and desmin-positive myotomal cells
(Fig. 7K-L). In rostralmost
somites facing the hindlimb, Pax3 expression becomes lower ventrally, whereas
many Six1-positive cells are still present
(Fig. 7M,N). Without Six
proteins, these cells lose Pax3 expression. They subsequently lose their
identity and migrate medially instead of invading the bud or differentiating
in the myotome (Fig. 7G,H,M,N),
even when Met and Lbx1 are transiently activated
(Fig. 6, parts II,III). Thus,
Six proteins are required to activate Pax3 expression and to impose a myogenic
fate to dermomyotomal cells of the somites. Interestingly, in the most caudal
somites of dKO embryos, the weak level of Lbx1 observed in hypaxial cells
expressing Pax3 suggests that Pax3 requires Six1 and Six4 to activate
Lbx1 gene to high level (Fig.
6, part III). At the thoracic level in dKO embryos, Pax3
expression is severely reduced and remains only detectable in a medial domain
of the somite (Fig. 7O-R).

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 7. Disruption of ventral and dorsal dermomyotomal lips in
Six1/Six4/
embryos at caudal (A-D), hindlimb (E-N), thoracic (O-R) and forelimb (S-X)
levels. Section (10 µm) of heterozygous (A,B,E,F,I,J,O,P,S,T,W) and dKO
(C,D,G,H,K,L,M,N,Q,R,U,V,X) E10.5 embryos hybridized with antibodies revealing
Pax3 protein in red (A,C,E,G,M,O,Q,S,U), ß-gal protein in green
(B,D,F,H,J,L,N,P,R,T,V), desmin (J,L) and laminin (I,K,W,X). Pax3 expression
is similarly expressed in rostral somites of both heterozygous and dKO
embryos, and is co-expressed with Six1 (compare C,D with A,B). At the hindlimb
level in the dKO embryos, we checked desmin, laminin, Six1 and Pax3 expression
in sacral somites facing the limb bud (G,H,K,L) and in more rostral somites
facing the limb bud (M,N). Laminin and desmin expression is found in the
myotomes in Six1-expressing cells on both wild-type and dKO sections
(white arrows in I-L). At this hindlimb level, the myotome of dKO embryos is
not disorganized. More rostrally, Pax3 expression is progressively lost
ventrally in lumbar somites at the hindlimb level, while most cells are
Six1 positive (compare G,H with M,N). At the thoracic level, Pax3
expression is restricted in the medial aspect of the dermomyotome of dKO
embryos (Q), while Six1 gene expression is found in the myotomes (R). More
rostrally, at the forelimb bud level, Six1-positive/Pax3-negative cells are
disorganized and have lost their identity; they also fail to enter the limb
bud in the double KO (compare S,T with U,V). At this level, the myotome of dKO
embryos is disorganized, as revealed by the low laminin expression (white
arrow in X), when compared with laminin expression in control embryos (white
arrow in W).
|
|
At the forelimb level in dKO embryos, the ventrolateral extension of Pax3
expression is severely reduced when compared with the control
(Fig. 7S,U). Six1 is uniformly
expressed dorsoventrally from the ectoderm to more internal mesenchyme
structures, including the myotome (Fig.
7V) instead of being restricted to myotomal and migrating cells
(Fig. 7T). In absence of
Six1/Six4, cells are unable to express Pax3, lose their myogenic identity and
are consequently dispersed and re-located beneath the ectoderm or more
medially. Although laminin expression that delimits the myotome is robust in
heterozygous mice (Fig. 7W), a
few laminin-positive cells are detected in the dKO at the forelimb level
(Fig. 7X), showing a severe
reduction of the myotome at this rostral level when compared with caudal
levels (Fig. 7K).
Six homeoproteins control early Mrf genes expression
We have previously shown that Six proteins were directly required for
myogenin transactivation during embryogenesis
(Spitz et al., 1998
). Although
no alteration of myogenin expression has been reported in
Six4/ embryos, we showed that Six1 was
required for early expression of myogenin in limbs but not in the myotome
(Laclef et al., 2003a
). We
show here that 90% of myogenin level was lost in the absence of Six1 and Six4
at E9.5 (Fig. 8, part II, A,B).
A few specific cells can nevertheless bypass Six signaling to activate
myogenin and probably give rise to the remaining epaxial muscles present in
Six1/Six4/
embryos at older stages. Their central localization within the myotome,
combined to the remaining Pax3 expression, suggest that these cells only
originate from the caudal lip of the dermomyotome. At E10.5, myogenin
expression remains very weak (Fig.
8, part III, A,B) at interlimb level, barely detectable in more
rostral somites and is faintly detectable on vibratome sections
(Fig. 8, part III, C-F). We
next examined the three myogenic determination genes Myf5, Myod1 and
Mrf4. In absence of Six1 and Six4, most of the
early Myod1 activation is blocked at E10.5
(Fig. 8, part IV).
Myod1 remains expressed in ventralhypaxial myotome of
interlimb somites (Fig. 8, part
IV, C-H). Early Myf5 expression at E9.25 (20-somite stage) is lower in dKO
embryos, even if correctly initiated in their epaxial compartment
(Fig. 8, part I). At E10.5, the
ventral and dorsal expression of Myf5 was lower, especially in rostral
somites, (Fig. 8, part V, A-H),
showing again the impaired ability of dermomyotomal lips in producing myogenic
cells. Myf5 is restricted to the center of the myotome when examined on
transverse sections (Fig. 8,
part V, C-H). At E9.5 and E10.5, Mrf4 is completely undetectable in the dKO
(Fig. 8, part VI; data not
shown), placing Six proteins upstream of this determination gene. At E11.5
Myod1 expression remain low in dKO embryo, and is undetectable in the most
ventral and dorsal positions (Fig.
8, part VII).

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 8. (Part I) Myf5 expression in E9.25 (20 somites stage) in heterozygous (A)
and dKO (B) embryos. Myf5 is expressed in the epaxial somites of heterozygous
embryos, and more faintly in epaxialrostral somites in dKO embryos. (Part II)
Myogenin expression in E9.5 embryos in heterozygous (A) and dKO (B) embryos. A
few positive myogenin-expressing cells are detected in the most rostral
somites of dKO embryos (arrows in B). (Part III) Myogenin expression in E10.5
heterozygous (A,C,E) and dKO (B,D,F) embryos. Vibratome sections at the
interlimb level (C,D) and forelimb level (E,F) show a strong decrease of
myogenin expression that is faintly detected in the epaxial region of dKO
embryos, hypaxial extension expression domain being lost. (Part IV) Myod1
expression in E10.5 heterozygous (A,C,E,G) and dKO (B,D,F,H) embryos. Most
Myod1 expression is lost in
Six1/Six4/ embryos,
and remaining expression can be visualized at the interlimb or forelimb levels
in the central and hypaxial somite (F,H). (Part V) Myf5 expression in
heterozygous (A,C,E,G) and in dKO (B,D,F,H) E10.5 embryos. Myf5 is mainly
detected in caudal lips of homozygous dKO animals at interlimb levels (B,
upper right), ventral and dorsal lip expression being lost (compare A with B).
This expression loss is well detected on vibratome sections at hindlimb (C,D),
interlimb (E,F) and forelimb (G,H) levels. In the dKO, at the forelimb level
the myotome is formed only of a central region expressing Myf5 (H). In the top
right-hand corners of A and B, magnification of interlimb Myf5 expression can
be seen that is restricted to the caudal region of the somites in the dKO
embryo (B). (Part VI) At E10.5, MRF4 expression is lost in
Six1/Six4/ embryos
(B), when compared with control hetererozygous expression (A). (Part VII)
Myod1 expression in heterozygous (A,C,E,G) and in
Six1/Six4/
(B,D,F,H) E11.5 embryos. A low diffuse Myod1 expression in interlimb somites
of dKO embryos is detected (B) with restricted ventral extension (B, and
enlargement in the top right-hand corner) when compared with Myod1 expression
in heterozygous embryos (A, enlargement in the top right-hand corner).
Vibratome sections (C-H) showing a faint Myod1 expression at hindlimb level,
with most dorsal and ventral extension being lost (C,D). At the interlimb
level, Myod1 expression is restricted to the central region of the myotome,
dorsal and ventral expression is lost (E,F). A low myotomal expression is
detected at the forelimb level (G,H).
|
|
Fgf signaling is altered in Six1Six4 KO embryos
The hypothesis that rib defects observed in dKO fetuses was caused by an
insufficient Fgf myotomal production was tested in dKO E10.5 embryos. Fgf4
expression is relatively reduced in the myotome of
Six1/Six4/
embryos, especially in more rostral somites, and Fgf6 expression seems more
severely diminished than Fgf4 in dKO embryos
(Fig. 9, parts I, II). Fgf8
expression is detected in the myotomes, AER, presomitic mesoderm and branchial
arches of heterozygous embryos, and this expression is generally unaffected in
Six1/Six4/
embryos, except in the third and fourth branchial arches
(Fig. 9, part III, A-E). Fgfr4
is expressed by the proliferating myotomal cells
(Marcelle et al., 1995
), and
presumably in proliferating cells of dKO embryos as well
(Fig. 9, part IV). Finally,
scleraxis expression in the syndetome has been shown to be controlled by Fgf
signaling provided by the adjacent myotome
(Brent and Tabin, 2004
).
Interestingly, no scleraxis expression is detected in the somites of
Six1/Six4/
embryos (Fig. 9, part V).
Moreover Six1 and Six4 proteins are not produced by normal syndetomal cells
(Fig. 9, part VI; data not
shown). These results suggest that some specific Fgf molecules emanating from
the somite are absent in dKO embryos, leading to the loss of early scleraxis
expression.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 9. Whole-mount in situ hybridization with Fgf4 (part I), Fgf6 (part II), Fgf8
(part III), Fgfr4 (part IV), scleraxis (parts V,VI) on heterozygous or dKO
E10.5 embryos and vibratome sections. (Part I) Fgf4 expression in heterozygous
(A,C,E) or dKO (B,D,F) embryos, showing a decrease of Fgf4 somitic expression,
AER expression is maintained (A,B). At the interlimb level (C-F), Fgf4
expression is restricted to the central region of the myotome. (Part II) Fgf6
expression in heterozygous (A,C) or dKO (B,D) embryos, showing a severe
reduction of Fgf6 in the somites (A,B) of the dKO embryo. Vibratome sections
at the interlimb level reveal a strong myotomal expression in the heterozygous
embryo (C), while a low signal can be detected in the dKO embryo (D). (Part
III) Fgf8 expression in heterozygous (A,D,F) or dKO (B,C,E,G) embryos showing
that somitic Fgf8 expression is maintained in the dKO embryos. Fgf8 is
expressed in the AER, presomitic mesoderm, otic placode and branchial arches
in wild-type or heterozygous embryo (A,D,F). At the somitic level, we detect
Fgf8 mRNA, mainly in the caudal lip and more faintly in rostral lip (A,D),
allowing Fgf8 to accumulate preferentially in the central myotome (F). In the
dKO embryos, presomitic, AER and somitic expression (C,E,G) are preserved,
while branchial arches expression (arrows in A and B) is lost (B). (Part IV)
Fgfr4 expression in heterozygous (A) or dKO (B) embryos at the interlimb level
showing a decrease of Fgfr4 expression in
Six1/Six4/
embryos. (Part V) Scleraxis expression in heterozygous (A) or dKO (B) embryos.
Scleraxis is expressed in tendon progenitors at the limb level (A), this
expression is preserved in the dKO embryo (B), while early somitic syndetomal
expression of scleraxis is lost in the dKO embryo (B). (Part VI) Scleraxis is
not expressed in Six1 somitic cell population. Double
Six1-lacZ (blue) and scleraxis (purple) heterozygous embryo
showing the different cell populations of the somites, which express
exclusively scleraxis (white arrow) or Six1 (black arrow).
|
|
 |
Discussion
|
|---|
An important finding from this study is that the delamination and migration
of the hypaxial precursors from the ventral lip to the limb buds are under the
control of Six homeoproteins. In absence of Six1 and Six4, cells that normally
give rise to the ventral lip of the dermomyotome lose Pax3 expression and lose
their identity; some of them are misrouted dorsally and detected beneath the
ectoderm, others are misrouted medially.
Met is the crucial factor necessary for myogenic cells of the VLL to
undergo an epithelial to mesenchymal transition prior to migration in the limb
bud (Bladt et al., 1995
). In
E10.5
Six1/Six4/
embryos, Met expression is correct in the most caudal somites but severely
reduced and highly diffuse more rostrally, thus completely preventing
migration. As Met has been demonstrated to be directly controlled by Pax3
(Relaix et al., 2003
), this
caudorostral downregulation of Met in
Six1/Six4/
embryos may be a direct consequence of the loss of Pax3. This could be
effectively the case for rostral somites where Pax3 expression is lost, but
not for the most caudal somites facing the hindlimb, where Pax3 seems
correctly activated, while Met is only faintly detected. These results
coincide with previous results showing that Met activation in cells migrating
from somite to limb was not entirely dependent on Pax3
(Mennerich et al., 1998
).
Thus, Six1 and Six4 control early steps of a genetic network involved in
ventral lip formation and that coordinate the expression of a set of genes
required for migration, including Pax3 and Met. Furthermore, while epaxial Met
expression is not altered in splotch mice
(Mennerich et al., 1998
) and
not increased in Pax3-FKHR mice (Relaix et
al., 2003
), it is abolished in all E10.5
Six1/Six4/ somites, even in
caudal somites where Pax3 expression is not yet extinguished. This result
suggests a direct control of Met by Six homeoproteins, independently of Pax3.
In the light of Six1 metastatic properties
(Ford et al., 1998
;
Yu et al., 2004
), these
results suggest that Six1 could control the metastatic behavior of
rhabdomyosarcoma cells through direct Met transactivation, as this
proto-oncogene has been implicated in the development of several human
cancers, including melanomas, breast cancer and rhabdomyosarcomas
(Sharp et al., 2002
).
Finally, our analysis provides strong evidence that Six1 and Six4
homeoproteins are also required for the activation of the Lbx1 gene
in the hypaxial myogenic precursors. In E10.5 dKO embryos, Lbx1 expression is
reduced but detectable in sacral somites facing the hindlimb where Pax3 is not
affected by the lack of Six homeoproteins. Lbx1 expression is completely
impaired in more rostral somites and hypoglossal chord. So far, Lbx1 has been
regarded as a Pax3 target because Lbx1 transcripts were not detectable in
splotch mice (Dietrich et al.,
1999
). These conclusions were compromised by the fact that cells
that would normally express Lbx1 are lost by the lack of Pax3
(Borycki et al., 1999
).
Furthermore Lbx1 expression is detectable in occipital somites of splotch
embryos contrary to what observed in
Six1/Six4/
embryos (Dietrich et al.,
1999
). These results suggesting a direct control of Lbx1 by Six
proteins are further supported by bandshift assays demonstrating the capacity
of Six1, Six4 and Six5 homeoproteins to bind the potential MEF3 site
identified in human and mouse Lbx1 promoter.
The absence of either Six1 or Six4 did not block Pax3 expression and cell
migration into the limb bud (Laclef et
al., 2003a
; Ozaki et al.,
2001
). Therefore, the double knockout analysis clearly
demonstrates the overlapping functions shared by Six1 and Six4 homeoproteins
to activate the myogenic migration program in somites through the control of
the expression of Pax3, Met and Lbx1genes.
Absence of Six1 and Six4 homeoproteins impaired induction of Pax3 and Mrfs leading to a severe trunk musculature hypoplasia
Epaxial myogenesis is more affected at the rostral level than at the
interlimb and caudal levels in
Six1/Six4/
embryos. This is observed from E10.5 and persisted throughout embryogenesis.
Pax3, Mrfs and other myotomal-specific genes expression is more severely
altered in rostral somites than in more caudal ones, giving rise to a more
severe disorganization of back muscle masses at the shoulder level than at the
interlimb and hip levels in dKO fetuses. This suggests that the regulatory
myogenic pathways operating in rostral somites are distinct from those
operating more caudally, and is reminiscent of the complex activation of the
Mrf4/Myf5 locus in different precursor populations
(Carvajal et al., 2001
;
Hadchouel et al., 2003
). E13.5
Six1/Six4/
embryos develop more serious defects in the body musculature than splotch
embryos, which are essentially affected in their most dorsal and ventral
muscles (Tremblay et al.,
1998
). Thus, the digenesis of more profound thoracic and abdominal
muscles in
Six1/Six4/
embryos appears to rely on an impaired determination and differentiation of
myotomal precursors. E10.5
Six1/Six4/
embryos, indeed, present a more severe decrease of Myf5 and Myod1 expression
in the myotome than what observed in splotch embryo
(Tajbakhsh et al., 1997
),
suggesting that Six homeoproteins can activate both genes in subpopulations of
myogenic precursors independently of Pax3. The genetic link between Myod1
expression and Six1 during limb myogenesis
(Laclef et al., 2003a
)
suggests a direct role for Six1 and Six4 in the transactivation of Myod1 in
myogenic precursors, while it has been established that the activation of
Myod1 by Pax3 is indirect (Relaix et al.,
2003
). It is also possible that impaired Myod1 expression is
dependent upon the decrease of Myf5 expression and loss of Mrf4 expression
(see below).
Most remaining myofibers in the dKO embryos arose from caudal dermomyotomal
lips, as epaxial and hypaxial lip structure is lost. These dermomyotomal
caudal lips precursors have been shown to contribute to myotome growth in its
dorsoventral extent (Kahane et al.,
1998
), are known to express specifically Delta1, and are
able to give rise to epaxial and hypaxial myocytes
(Gros et al., 2004
;
Kahane et al., 1998
).
Myogenin expression is dramatically reduced in the myotome of
Six1/Six4/
embryos at E9.5 and E10.5. Only a few positive cells are detected in the more
central-epaxial part of the myotome. The comparative analysis of myogenin
expression between
Six1/Six4/
and splotch mutants embryos (Tajbakhsh et
al., 1997
) tends to demonstrate the dependence of myogenin
activation by Six proteins, as expected by our previous finding
(Spitz et al., 1998
). The
observation that somitic expression of myogenin was preserved in
Six1/ or in
Six4/ embryos, and that limbs expression of
myogenin was only delayed in Six1/ embryos
(Laclef et al., 2003a
;
Ozaki et al., 2001
) probably
reflected again the compensation mechanism that exists between Six1 and Six4.
The remaining myogenin and ß-gal-positive cells in the center of the
myotomes suggest that a specific population of myogenic cells can activate
myogenin and an alternative myogenic program in the absence of Six proteins,
as already proposed (Laclef et al.,
2003a
).
Surprisingly, Mrf4 expression is completely lost in
Six1/Six4/
embryo. MRF4 has been recently identified as a key determination gene
controlling the activation of Myod1 in the myotome, in parallel to Myf5
(Kassar-Duchossoy et al.,
2004
). The lack of Mrf4 in
Six1/Six4/
embryo may thus participate in the downregulation of myotomal Myod1
expression. Myod1 expression has been shown to be under two complementary
genetic pathways involving Myf5 and Pax3
(Tajbakhsh et al., 1997
).
Whether Myod1 activation by Six proteins follows the Myf5 or Pax3 network, or
both, remains to be determined.
We have demonstrated that in the absence of Six1 and Six4 myogenic factors,
the formation of the myotome is first compromised by a loss of Pax3 and second
by an impaired activation of the Mrf proteins in the myogenic precursors
already present in the myotome. It also shows that although impaired at
multiple levels absence of ventral and dorsal lips, and decrease of
Mrf protein expression primary myogenesis can nevertheless take place,
mainly owing to contribution of caudal lips in which Pax3 is still expressed
independently of Six1 and Six4.
Increased apoptosis in somites of Six1/Six4/ embryos
Although there is some evidence that Six1 could control cell proliferation
(Yu et al., 2004
),
proliferation deficiencies were not detected in the myogenic lineage of
Six1/Six4/
embryos. However, Six1 and Six4 appeared necessary to prevent cells from
apoptosis and to induce myogenic differentiation through myogenin induction
and the accompanying cell cycle withdrawal
(Zhang et al., 1999
). Cells in
the branchial arches, in the DRG and in the ventrolateral dermomyotome of the
dKO embryos were found to lose their identity and die by apoptosis.
Interestingly, this phenotype has been reported in Drosophila, where
absence of sine oculis does not prevent cell proliferation but
induces apoptosis of those cells that are unable to progress in their
differentiation (Cheyette et al.,
1994
). Interestingly, apoptosis has been also reported in
Pax3/ embryos at the somitic level
(Borycki et al., 1999
). It has
been suggested that overexpression or misexpression of one protein of the
Pax-Six-Eya-Dach network triggered a default apoptotic program
(Clark et al., 2002
).
Apoptosis has also been detected in Six1/
embryos in the metanephric mesenchyme (Xu
et al., 2003
). This suggests that different cell types adopt the
same strategy facing the absence of Six homeoproteins, or that Six proteins
are important actors for cell survival.
Six1 and Six4 control Fgf production in the myotomes
Several Fgf molecules are produced by the somites
(Karabagli et al., 2002
). We
find in fact that Fgf4 and Fgf6 ventrolateral somitic expression is greatly
diminished in
Six1/Six4/
E10.5 embryos. We can hypothesize that as Fgf molecules produced by the
ventrolateral myotome, i.e. Fgf6 and Fgf4, are lacking in E10.5
Six1/Six4/
embryos, scleraxis transcription is delayed. In fact, while early scleraxis
activation is inhibited, in E12.5 embryos, scleraxis expression becomes
detectable (D. Duprez, personnal communication). Our results support the
hypothesis of Fgf signaling by the myotome is required to induce scleraxis
and, hence, the syndetomal compartment, in agreement with recent findings
(Brent et al., 2005
). As axial
tendon formation can take place during mouse embryogenesis even in the absence
of scleraxis (Ronen Schweitzer, personal communication), the tendons observed
at the axial level in E18.5 fetuses is not in conflict with a default early
induction of scleraxis in
Six1/Six4/
embryos.
We already reported that Six1/ mice had
severe rib and skeletal craniofacial defects. Rib defects, as discussed
already (Laclef et al.,
2003a
), are observed in several other KO that prevent axial
myogenesis. Fgf and Pdgfa signaling is required for correct rib growth and
both signaling pathways are diminished in the Myf5 KO that is devoid of early
myotome and Mrf4 expression (Grass et al.,
1996
; Kassar-Duchossoy et al.,
2004
; Patapoutian et al.,
1995
; Tallquist et al.,
2000
), and one can hypothesize that it is the case for the other
KO in which correct hypaxial myogenesis is impaired. Absence of early
ventrolateral differentiated myotome producing Fgf signaling, as observed in
Six1/Six4/
embryos should preclude growing of the sternal region of the ribs
(Evans, 2003
;
Huang et al., 2003
). Six1 and
Eya1 have been shown already to control Fgf3 and Fgf10 signaling during kidney
and otic development (Xu et al.,
1999
; Zheng et al.,
2003
), suggesting that one signaling pathway controlled by the
Pax-Six-Eya network may that of the Fgf signaling affecting different types of
organogenesis.
Pax-Six-Eya genetic loop
The demonstration of an epistatic relationship between
Six1/Six4 genes and Pax3 gene in myogenic precursors
originating from the lateral dermomyotome of the somites is consistent with
the genetic link characterized during early kidney development in the mouse
embryo, where Pax2 expression has been shown to be markedly reduced in the
metanephric mesenchyme of Six1 mutant mice
(Xu et al., 2003
). The genetic
hierarchy placing sine oculis downstream eyeless in
Drosophila (Halder et al.,
1998
) does not seem to be conserved during myogenic development
nor during the early organogenesis of kidney, as Six1 expression is not
altered in the metanephric mesenchyme of Pax2 mutant mice embryo
(Xu et al., 2003
).
Interestingly, although Six1/Six4 control Pax3 expression in the lateral
dermomyotome of the occipital, cervical, thoracic and lumbar somites, Pax3 is
activated independently of Six proteins in the lateral dermomyotome of sacral
and caudal somites, and in the anterior and posterior lips of the dermomyotome
of all somites along the anteroposterior axis. Altogether, these results are
reminiscent to the recent observation that Lbx1 gene is activated by Hox
proteins in the somites facing the limb buds
(Alvares et al., 2003
), and
suggest that Hox proteins that control the axial identity of somites
(Burke, 2000
) may, in
cooperation with Six proteins, control Pax3, Lbx1 and, more generally,
hypaxial myogenesis.
 |
ACKNOWLEDGMENTS
|
|---|
We thank A. K. Voss and P. Gruss for the gift of ES cells, S. Tajbakhsh, C.
Marcelle, C. Birchmeier, G. Martin, H. H. Arnold, E. Olson and C. Ponzetto for
probes and antibodies, and D. Metzger for the plox2hygro plasmid. We thank F.
Relaix and M. Lagha for their helpful support concerning in situ analysis, C.
Laclef and D. Duprez for helpful discussions, and A. Baudinière for
technical assistance during Six4 genomic cloning. We thank R. Schweitzer and
D. Duprez for communicating results before publication. We thank M.
Buckingham, D. Daegelen, M. Morgan and S. Tajbakhsh for helpful critical
reading of the manuscript. R.G. was supported by a fellowship from the
Ministère de la Recherche et de l'Education nationale, from the
Association Française contre les Myopathies (AFM) and from the
Fondation pour la Recherche Médicale (FRM). Financial support for this
work has been provided by the Institut National pour la Santé et la
Recherche Médicale (INSERM), the Centre National de la Recherche
Scientifique (CNRS), the AFM, and by the Action Concertée Incitative
0220514. The contribution of the Région Ile de France to the Institut
Cochin animal care facility is also acknowledged.
 |
Footnotes
|
|---|
* These authors contributed equally to this work 
 |
REFERENCES
|
|---|